Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Rebbeck

Showing results (231-240 of 371) with videos related to

Pageof 38
Sort By:
European Urology Focus|May 4, 2021
Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2Patrick Leo, Sacheth Chandramouli, Xavier Farré, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based studyMarianne Berwick, Irene Orlow, Amanda J Hummer, et al.
Cancer Causes & Control : CCC|January 9, 2007
Ambient UV, personal sun exposure and risk of multiple primary melanomasAnne Kricker, Bruce K Armstrong, Chris Goumas, et al.
JCO Precision Oncology|July 15, 2026
Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-ProstateMartin W Schoen, Jiannong Li, Sihang Zeng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Theresa Wagner, et al.
Clinical Breast Cancer|February 14, 2008
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriersTara M Friebel, Susan M Domchek, Susan L Neuhausen, et al.
International Journal of Epidemiology|September 28, 2007
Assessment of cumulative evidence on genetic associations: interim guidelinesJohn P A Ioannidis, Paolo Boffetta, Julian Little, et al.
Carcinogenesis|November 1, 2005
Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma StudyRobert C Millikan, Amanda Hummer, Colin Begg, et al.
Cell Reports|January 22, 2026
Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populationsXiaowen Hu, Jie Huang, Jiao Yuan, et al.
Cancer Research|April 5, 2017
Precancer Atlas to Drive Precision Prevention TrialsAvrum Spira, Matthew B Yurgelun, Ludmil Alexandrov, et al.
Pageof 38

Showing results (231-240 of 371) with videos related to

Sort By:
Pageof 38
European Urology Focus|May 4, 2021
Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2Patrick Leo, Sacheth Chandramouli, Xavier Farré, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based studyMarianne Berwick, Irene Orlow, Amanda J Hummer, et al.
Cancer Causes & Control : CCC|January 9, 2007
Ambient UV, personal sun exposure and risk of multiple primary melanomasAnne Kricker, Bruce K Armstrong, Chris Goumas, et al.
JCO Precision Oncology|July 15, 2026
Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-ProstateMartin W Schoen, Jiannong Li, Sihang Zeng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2005
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Theresa Wagner, et al.
Clinical Breast Cancer|February 14, 2008
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriersTara M Friebel, Susan M Domchek, Susan L Neuhausen, et al.
International Journal of Epidemiology|September 28, 2007
Assessment of cumulative evidence on genetic associations: interim guidelinesJohn P A Ioannidis, Paolo Boffetta, Julian Little, et al.
Carcinogenesis|November 1, 2005
Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma StudyRobert C Millikan, Amanda Hummer, Colin Begg, et al.
Cell Reports|January 22, 2026
Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populationsXiaowen Hu, Jie Huang, Jiao Yuan, et al.
Cancer Research|April 5, 2017
Precancer Atlas to Drive Precision Prevention TrialsAvrum Spira, Matthew B Yurgelun, Ludmil Alexandrov, et al.
Pageof 38